Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol

被引:0
|
作者
Trauth, Janina [1 ]
Schuler, Rahel [2 ]
Waitz, Markus [2 ]
Ehrhardt, Harald [2 ,4 ]
Fritzenwanker, Moritz [3 ]
Herold, Susanne [1 ]
机构
[1] Justus Liebig Univ, Dept Med Internal Med Infect Dis & Infect Control, Giessen, Germany
[2] Justus Liebig Univ, Dept Gen Pediat & Neonatol, Giessen, Germany
[3] Justus Liebig Univ Giessen, Inst Med Microbiol, Giessen, Germany
[4] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Div Neonatol & Pediat Intens Care Med, Ulm, Germany
关键词
Multi drug resistance; Stenotrophomonas maltophilia; Cefiderocol; Pneumogenic sepsis; Neonate;
D O I
10.1007/s15010-024-02404-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits
    Petraitis, Vidmantas
    Petraitiene, Ruta
    Kavaliauskas, Povilas
    Naing, Ethan
    Garcia, Andrew
    Ishibashi, Naoki
    Georgiades, Benjamin
    Echols, Roger
    Bonomo, Robert A.
    Yamano, Yoshinori
    Satlin, Michael J.
    Walsha, Thomas J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (10)
  • [2] Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature Review
    Vena, Antonio
    Mezzogori, Laura
    Castaldo, Nadia
    Corcione, Silvia
    Pascale, Renato
    Giannella, Maddalena
    Pinna, Simone Mornese
    Giacobbe, Daniele Roberto
    Bavaro, Davide Fiore
    Scaglione, Vincenzo
    Fumarola, Benedetta
    Pagani, Gabriele
    De Rosa, Francesco Giuseppe
    Bartoletti, Michele
    Bassetti, Matteo
    ITA GIOVANI Young Investigators Grp Soc Italiana Terapia Antinfettiva, Giuseppe
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (03) : 657 - 669
  • [3] Successful Use of Cefiderocol to Treat a Multidrug-resistant Stenotrophomonas maltophilia Ventilator-associated Pneumonia in an Extremely Preterm Neonate
    Koirala, Archana
    Krishnappa, Bharath
    Banh, Caroline
    Brandenburg, Ulrike
    Findlay, Michael
    Williams, Phoebe C. M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (11) : 1012 - 1016
  • [4] Suitable empiric antibiotic therapy saves lives in nosocomial pneumonia caused by Stenotrophomonas maltophilia
    Yilmaz, Guerdal
    Ozsu, Savas
    Koksal, Iftihar
    Ozlu, Tevfik
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2010, 40 (01) : 99 - 103
  • [5] Stenotrophomonas maltophilia as a Pathogen of Nosocomial Pneumonia: Seven Case Reports
    Ozdemir, Levent
    Ozdemir, Burcu
    Havlucu, Yavuz
    TURKISH THORACIC JOURNAL, 2013, 14 (02) : 72 - 74
  • [6] Stenotrophomonas maltophilia as a nosocomial pathogen
    Köseoglu, Ö
    Sener, B
    Gülmez, D
    Altun, B
    Gür, D
    MICROBIOLOGICA, 2004, 27 (03): : 273 - 279
  • [7] Cefiderocol for Stenotrophomonas maltophilia prosthetic joint infection: a case report
    Chambers, MaKenzie M.
    Gutowski, Christina J.
    Doktor, Katherine
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2023, 10
  • [8] Clinical Importance of Stenotrophomonas maltophilia Nosocomial Pneumonia Due to its High Mortality in Hemodialysis Patients
    Wakino, Shu
    Imai, Eiko
    Yoshioka, Kyoko
    Kamayachi, Tadashi
    Minakuchi, Hitoshi
    Hayashi, Koichi
    Inamoto, Hajime
    Itoh, Hiroshi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2009, 13 (03) : 193 - 198
  • [9] Cefiderocol as a Treatment Option for Stenotrophomonas maltophilia Causing Hospital- Acquired/Ventilator-Associated Pneumonia
    Rashid, Muhammad Humayoun
    Bukhari, Syeda Neelam Yamin
    Mousa, Aliaa
    Aziz, Ahmed Ali
    Hakobyan, Knkush
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [10] In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia
    Nakamura, Rio
    Oota, Merime
    Matsumoto, Shuhei
    Sato, Takafumi
    Yamano, Yoshinori
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)